DCC2459 |
Gwl-78 |
Novel modulator of NF-Y transcription, inhibiting the binding of NF-Y to DNA, blocking cellular proliferation and cell cycle progression, interacting with a variety of CCAAT-containing promoters leading to p53-independent cell cycle arrest |
|
DCC2460 |
Gx-395 |
Novel inhibitor of Nav1.7 |
|
DCC2461 |
Gx-585 |
Novel potent inhibitor of NaV1.7 and highly selective against NaV1.5, having limited selectivity against NaV1.1 and NaV1.2 |
|
DCC2462 |
Gx-629 |
GX-936 analog, antagonist of voltage-gated sodium 1.7 (Nav1.7) channels |
|
DCC2463 |
Gyki-53655 |
AMPA antagonist |
|
DCC2464 |
Gyramide A |
Novel bacterial DNA gyrase inhibitor, exhibiting antimicrobial activity and inhibiting bacterial cell division |
|
DCC2465 |
H-0104 Dihydrochloride |
Novel Rho-associated coiled coil-formed protein kinase (ROCK) inhibitor, exerting strong intraocular pressure (IOP)-lowering effects into the eyes of monkeys |
|
DCC2466 |
H-0106 Dihydrochloride |
Novel Rho-associated coiled coil-formed protein kinase (ROCK) inhibitor, exerting strong intraocular pressure (IOP)-lowering effects into the eyes of monkeys |
|
DCC2467 |
h1-agonist-39 |
Novel full H1 agonist |
|
DCC2468 |
H2-003 |
Novel class of selective diacylglycerol acyltransferase 2 (DGAT2) inhibitor |
|
DCC2469 |
H2-005 |
Novel class of selective diacylglycerol acyltransferase 2 (DGAT2) inhibitor |
|
DCC2470 |
H2a-4t |
Novel water-soluble and biocompatible small-molecule near-infrared II (NIR-II) fluorescent dye |
|
DCC2471 |
h2lassbio-1064 |
Inhibitor of acetic acid-induced writhing response |
|
DCC2472 |
H-4073 |
Novel inhibitor of STAT3 activation, inhibiting head and neck cancer cell proliferation in a dose dependent manner |
|
DCC2473 |
H77-77 |
Inhibitor of monoamine oxidase (MAO) |
|
DCC2474 |
Ha Protein Inhibitor 1 |
Novel hemagglutinin (HA) protein inhibitor, inhibiting entry and replication of diverse influenza viruses via the HA protein, showing potent antiviral activity against diverse H1N1, H5N1, and H3N2 influenza viruses encoding HA proteins from both groups 1 |
|
DCC2475 |
Halauxifen |
Herbicide, being used for the control of broad-leaved weeds in cereals and oilseed rape |
|
DCC2476 |
Halobetasol |
Topical corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictor activities, inducing phospholipase A2 inhibitory proteins, activating gene expression of anti-inflammatory proteins mediated via the corticosteroid receptor response element |
|
DCC2477 |
Halofantrine Hydrochloride |
Antimalarial, binding to plasmpesin, a haemoglobin degrading enzyme unique to the malarial parasites |
|
DCC2478 |
Halofenate |
Selective peroxisome proliferator-activated receptor gamma (PPAR-gamma) modulator with antilipidemic activity |
|
DCC2479 |
Haloprotac2 |
Novel HaloPROTAC degrader, inducing degradation of HaloTag fusion proteins |
|
DCC2480 |
Haloquinone |
Novel Wnt inhibitor, blocking Wnt signaling downstream of beta-Catenin |
|
DCC2481 |
Haploscleridamine |
Novel inhibitor of cathepsin K (CatK) |
|
DCC2482 |
Haptamide B |
Novel selective inhibitor of Hap2/3/4/5p mediated transcription in vivo. |
|
DCC2483 |
Harringtonolide |
Natural antiproliferative, antifungal, antitumor agent, suppressing the epithelial-mesenchymal transition (EMT) process and inhibiting activation of the FAK/Src/STAT3 signaling pathway in A375 cells, targeting RACK1 to suppress cancer cell migration |
|
DCC2484 |
hat Inhibitor C107 |
Novel p300/CBP HAT inhibitor |
|
DCC2485 |
Hatric |
Precursor for HATRIC-based ligand receptor capture (HATRIC-LRC) |
|
DCC2486 |
Hbf-0079 |
Hepatocellular carcinoma (HCC)-selective cytotoxin, suppressing AKT anti-apoptotic signaling |
|
DCC2487 |
Hc102a |
Novel Inhibitor of Mycobacterium tuberculosis DosRST signaling and persistence |
|
DCC2488 |
Hc103a |
Novel Inhibitor of Mycobacterium tuberculosis DosRST signaling and persistence |
|